?:authorAffiliation
|
-
[\'Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK.\', \'Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore della Carità Hospital, Novara, Italy.\', \'Department of Medical Oncology, University of Ioannina, Ioannina, Greece; Chief Medical Officer, European Society for Medical Oncology, Lugano, Switzerland.\', \'Department of Medical Oncology, Center for Cancer Immunotherapy, Institut Curie, Paris, France.\', \'Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK; Department of Biotechnology and Applied Clinical Sciences, University of L\'Aquila, L\'Aquila, Italy. Electronic address: a.cortellini@imperial.ac.uk.\', \'Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore della Carità Hospital, Novara, Italy. Electronic address: david.pinato@imperial.ac.uk.\']
|